These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 3085965)

  • 1. The disposition and in vivo covalent binding to liver DNA of the monoazodyes 6-(p-dimethylaminophenylazo)benzothiazole (6BT) and 5-(p-dimethylaminophenylazo)indazole (5I) after administration to the rat.
    Dashwood RH; Combes RD; Ashby J
    Carcinogenesis; 1986 Jun; 7(6):1029-33. PubMed ID: 3085965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA-binding studies with 6BT and 5I: implications for DNA-binding/carcinogenicity and DNA-binding/mutagenicity correlations.
    Dashwood RH; Combes RD; Ashby J
    Mutat Res; 1988 Mar; 198(1):61-8. PubMed ID: 3127700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined radiolabelling distribution and covalent DNA-binding studies to discriminate between a carcinogen/noncarcinogen pair of monoazo dyes related to the hepatocarcinogen butter yellow (DAB).
    Dashwood RH; Combes RD; Ashby J
    Arch Toxicol Suppl; 1987; 11():99-101. PubMed ID: 3115233
    [No Abstract]   [Full Text] [Related]  

  • 4. The possible role of azoreduction in the bacterial mutagenicity of 4-dimethylaminoazobenzene (DAB) and 2 of its analogues (6BT and 5I).
    Ashby J; Lefevre PA; Callander RD
    Mutat Res; 1983 Mar; 116(3-4):271-9. PubMed ID: 6403852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azoreductase activity of Sprague Dawley and Wistar-derived rats towards both carcinogenic and non-carcinogenic analogues of 4-dimethylaminophenylazobenzene (DAB).
    Elliott BM
    Carcinogenesis; 1984 Aug; 5(8):1051-5. PubMed ID: 6430584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity of the potent rat hepatocarcinogen 6BT to the liver of transgenic (lacI) rats: consideration of a reduced mutation assay protocol.
    Lefevre PA; Tinwell H; Ashby J
    Mutagenesis; 1997 Jan; 12(1):45-7. PubMed ID: 9025097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic gene mutations induced in Big Blue rats by both the potent rat liver azo-carcinogen 6BT and its reported noncarcinogenic analogue 5BT.
    Fletcher K; Soames AR; Tinwell H; Lefevre PA; Ashby J
    Environ Mol Mutagen; 1999; 34(2-3):148-53. PubMed ID: 10529739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of an in vivo/in vitro rat liver DNA repair assay to predict the relative rodent hepatocarcinogenic potency of 3 new azo mutagens.
    Beije B; Ashby J
    Carcinogenesis; 1985 Apr; 6(4):611-5. PubMed ID: 3921275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An assessment of the in vivo rat hepatocyte DNA-repair assay.
    Ashby J; Lefevre PA; Burlinson B; Penman MG
    Mutat Res; 1985; 156(1-2):1-18. PubMed ID: 3923346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positive and negative control observations for the in vivo/in vitro rat liver assay for unscheduled DNA synthesis (UDS).
    Ashby J; Trueman RW; Mohammed R; Barber G
    Mutagenesis; 1987 Nov; 2(6):489-90. PubMed ID: 3127659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-p-Dimethylaminophenylazobenzothiazole: a potent hepatocarcinogen in the rat.
    Elliott BM; Robinson M; Ashby J
    Cancer Lett; 1983 Nov; 21(1):69-76. PubMed ID: 6416666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uptake and hepatobiliary fate of two hepatocarcinogens, N,N-dimethyl-4-aminoazobenzene and 3'-methyl-N,N-dimethyl-4-aminoazobenzene, in the rat.
    Samuels AR; Bhargava MM; Levine WG
    Cancer Res; 1983 Oct; 43(10):4816-21. PubMed ID: 6411333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection by chlorophyllin against the covalent binding of 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) to rat liver DNA.
    Dashwood RH
    Carcinogenesis; 1992 Jan; 13(1):113-8. PubMed ID: 1733563
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of unscheduled DNA synthesis in liver and micronucleus in bone marrow of rats exposed in vivo to the benzidine-derived azo dye, Direct Black 38.
    Beije B
    Mutat Res; 1987 Apr; 187(4):227-34. PubMed ID: 3104779
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Observed convergence of the Salmonella plate and pre-incubation assays when employing varying levels of S9.
    Callander RD
    Mutagenesis; 1986 Nov; 1(6):439-43. PubMed ID: 3137416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Covalent binding of 4-dimethylaminophenylazo-3H-benzene (butter yellow) metabolites with liver ribosomal RNA: the dissociation of the binding mechanism from the orotic acid incorporating system.
    Roberts JJ; Warwick GP
    Int J Cancer; 1966 Nov; 1(6):573-8. PubMed ID: 4962785
    [No Abstract]   [Full Text] [Related]  

  • 17. Uptake, metabolism, and secretion of 3'-methyl-N,N-dimethyl-4-aminoazobenzene by isolated perfused rat liver.
    Samuels AR; Theilmann L; Stollman YR; Wolkoff AW; Bhargava MM
    Drug Metab Dispos; 1987; 15(2):184-8. PubMed ID: 2882975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of in vivo DNA binding of mercaptobenzothiazole to selected tissues of the rat.
    Brewster DW; Mirly KJ; Wilson AG; Barnett JW
    Biochem Biophys Res Commun; 1989 Nov; 165(1):342-8. PubMed ID: 2590232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity to Salmonella of four derivatives of the azo mutagen 5I: some implications for structure--activity databases and the evaluation of combinations of mutagens.
    Dashwood RH; Combes RD; Paton D; Ashby J
    Mutagenesis; 1986 Jul; 1(4):261-5. PubMed ID: 3137411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutagenic activation of selected aminoazo compounds by rat liver: evidence for a cytochrome P-448 dependent reaction.
    Mori Y; Niwa T; Toyoshi K
    Gan; 1983 Aug; 74(4):483-92. PubMed ID: 6414872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.